EHRA Premium Access

Is there a role for anti-arrhythmic drugs or catheter ablation?

Congress Presentation

About the speaker

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
99 presentations

3 more presentations in this session

The impact of atrial fibrillation in HFREF and HFPEF

Speaker: Professor A. Stewart Coats (Coventry, GB)


Permanent atrial fibrillation in HFREF and HFPEF: when and how to control rate?

Speaker: Professor D. Kotecha (Birmingham, GB)


The mitral valve in patients with AF and HF - Do we need specific therapy?

Speaker: Professor R. Rosenhek (Vienna, AT)


Access the full session

New insights on atrial fibrillation in patients with HFrEF and HFpEF: treatment strategies to optimise outcome

Speakers: Professor F. Ruschitzka, Professor A. Stewart Coats, Professor D. Kotecha, Professor R. Rosenhek

About the event


EHRA 2018

18 March - 20 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb